AMENDED AND RESTATED INVESTMENT AGREEMENTInvestment Agreement • June 11th, 2015 • Rich Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This AMENDED AND RESTATED INVESTMENT AGREEMENT (the “Agreement”), dated as of June, 10, 2015 (the “Execution Date”), is entered into by and between Rich Pharmaceuticals, Inc., a Nevada corporation (the “Company”), with its principal executive office at 9595 Wilshire Blvd, Suite 900, Beverly Hills, CA 90212, and LG Capital Funding, LLC, a New York limited liability company (the “Investor”), with its principal executive office at 1218 Union Street, Suite #2, Brooklyn, NY 11225.
